Zydus Lifesciences Limited — Updates, 19-12-2025: Press Release
19-12-2025 | 09:49 am
19-12-2025 | 09:49 am
Zydus Lifesciences signed an exclusive agreement with Myriad Genetics (US) to launch advanced cancer-risk assessment diagnostic tests in India. This move expands Zydus's precision oncology offerings, aiming to enhance patient care and market presence.
No comments yet. Be the first to comment!
